Form 4: Hologic Director Nanaz Mohtashami Reports Acquisition of Stock and Stock Options

Director Nanaz Mohtashami reports acquisition of Hologic common stock and stock options.

Summary

• On March 7, 2024, Nanaz Mohtashami, a director of Hologic Inc., reported acquiring 1,572 shares of common stock.
• These shares were received as restricted stock units that vest on the date of the 2025 Annual Meeting of Stockholders and are settled in shares of common stock on a one-for-one basis.
• Mohtashami also acquired non-qualified stock options for 4,536 shares of common stock with an exercise price of $76.32, which become exercisable on the date of the 2025 Annual Meeting of Stockholders and expire on 03/07/2034.
• Following these transactions, Mohtashami directly owns 2,317 shares of Hologic common stock and 4,536 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock and option acquisition by a director, which can be seen as a positive sign of confidence but doesn't inherently indicate strong positive or negative sentiment.

Positives

• The acquisition of shares and stock options by a director could be interpreted positively, signaling confidence in the company's future performance.

Future Outlook

The restricted stock units vest and the options become exercisable on the date of the 2025 Annual Meeting of Stockholders.

Industry Context

This filing is a routine disclosure related to insider transactions and provides insight into the compensation structure for Hologic's directors.

Comparison to Industry Standards

• Stock options and restricted stock units are common forms of executive compensation in publicly traded companies, including those in the medical technology sector like Hologic.
• Companies such as Intuitive Surgical, Medtronic, and Stryker also utilize similar equity-based compensation plans to align the interests of their executives and directors with those of shareholders.

Stakeholder Impact

• The acquisition of shares and options by a director can positively influence shareholder sentiment.

Key Dates